Surgery Partners Stock Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
Buy Signal from Moving Average: Indicates potential upward movement.
Sell Signal (MA)
Sell Signal from Moving Average: Indicates potential downward movement.
AI Analysis of SGRY
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
Surgery Partners stock price ended at $31.19 on Thursday, after losing 2.59%
(Updated on Oct 03, 2024)
Buy or Hold candidate since Sep 13, 2024
Gain 0.61%
The Surgery Partners stock price fell by -2.59% on the last day (Thursday, 3rd Oct 2024) from $32.02 to $31.19. During the last trading day the stock fluctuated 4.95% from a day low at $30.69 to a day high of $32.21. The price has fallen in 7 of the last 10 days and is down by -5.86% for this period. Volume has increased on the last day by 57 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 526 thousand shares were bought and sold for approximately $16.40 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 20.19% during the next 3 months and, with a 90% probability hold a price between $34.97 and $43.76 at the end of this 3-month period.
SGRY Signals & Forecast
The Surgery Partners stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $32.05. On a fall, the stock will find some support from the long-term average at approximately $31.18. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, August 23, 2024, and so far it has fallen -7.42%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Surgery Partners stock
Surgery Partners finds support from accumulated volume at $29.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.52 between high and low, or 4.95%. For the last week, the stock has had daily average volatility of 3.40%.
Our recommended stop-loss: $29.89 (-4.17%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 28 days ago.)
Trading Expectations (SGRY) For The Upcoming Trading Day Of Friday 4th
For the upcoming trading day on Friday, 4th we expect Surgery Partners to open at $31.36, and during the day (based on 14 day Average True Range), to move between $29.99 and $32.39, which gives a possible trading interval of +/-$1.20 (+/-3.85%) up or down from last closing price. If Surgery Partners takes out the full calculated possible swing range there will be an estimated 7.69% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $32.02 (2.66%) than the support at $29.64 (4.97%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Surgery Partners stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Surgery Partners stock to perform well in the short-term.
Current score:
2.454
Buy Candidate
Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on October 4, 2024 - $31.36 ( 0.556%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for SGRY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 32.88 | 5.43% |
| R2 | 32.30 | 3.57% |
| R1 | 31.94 | 2.42% |
| Price | 31.19 | |
| S1 | 30.78 | -1.31% |
| S2 | 30.42 | -2.46% |
| S3 | 29.84 | -4.32% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 33.69 | 8.02% |
| R2 | 32.50 | 4.20% |
| R1 | 32.02 | 2.66% |
| Price | 31.19 | |
| S1 | 29.64 | -4.97% |
| S2 | 29.10 | -6.70% |
| S3 | 29.05 | -6.86% |
FAQ
Click here for our free guide on how to buy Surgery Partners Stock.
